Newborn with nonimmune hydrops fetalis - the experience of a tertiary center.
DOI:
https://doi.org/10.20344/amp.797Abstract
Nonimmune hydrops fetalis is a rare affection that can result from several disorders. Notwithstanding with the advances in the diagnosis and treatment, its morbidity and mortality are still very high. The purpose of this study was to characterize the newborn population with nonimmune hydrops fetalis admitted to our unit during the last ten years.A descriptive review of the newborns with nonimmune fetalis hydrops admitted to the Neonatal Intensive Care Unit of Hospital de São João, between 1997 and 2006. Data on pregnancy, delivery, perinatal approach, etiological evaluation and outcome were collected.Nineteen neonates (9M/10F) with a median gestational age of 32 weeks (26-39) and a median birth weight of 2695 g (884-4270) were studied. Sixteen (84%) were preterm. Antenatal diagnosis was made in fourteen (74%) cases, and two received in uterus treatment. C-section was performed in fourteen (74%) cases. Sixteen (84%) neonates needed resuscitation in the delivery room. Aetiological diagnosis was made in 89% (n = 17): cardiovascular (n = 5), haematological (n = 5), metabolic (n = 2), infectious (n = 2), chromosomal (n = 1), lymphatic malformation (n = 1) and meconium peritonitis (n = 1). The median length of hospital stay was 17 days. Thirteen (68%) neonates were deceased.The occurrence and admission of newborns with nonimmune hydrops fetalis to our unit was rare. The aetiological diagnosis was made in 89% and mortality rate was 68%. The worse prognosis was related to preterm birth, anaemia, cardiac malformation, metabolic disorder, congenital infection and chromosomopathy. The prompt aetiological diagnosis and its proper ante and postnatal management are the most important steps to reduce the morbidity and mortality of this condition.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.